Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancer Treatment

Journal Title: Journal of Mathematical and Fundamental Sciences - Year 2017, Vol 49, Issue 3

Abstract

Intact monoclonal antibodies with a high molecular weight tend to have a poor pharmacokinetic profile and tumor penetration, and potential for eliciting host antibody responses. F(ab’)2 fragments smaller than intact monoclonal antibodies that still maintain antigen binding could solve this problem. The objective of this study was to optimize the digestion process of nimotuzumab, an anti-EGFR monoclonal antibody, into its F(ab’)2 fragment and investigate its potential as a therapeutic radioimmunoconjugate. Optimal conditions for digestion of nimotuzumab to its F(ab’)2 fragment were found to be 6 hours of digestion time with a pH of 3.5 and 1:100 mol ratio of pepsin to nimotuzumab. The purity of the F(ab’)2-nimotuzumab was confirmed by SDS-PAGE and HPLC analysis. Prior to its labeling with lutetium-177 radionuclide, the nimotuzumab-F(ab’)2 was conjugated to DOTA-PAMAM dendrimer [DOTA denotes 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, PAMAM denotes poly(amidoamine)] to form conjugate of (DOTA)n-PAMAM-[nimotuzumab-F(ab’)2]. Radiolabeling of DOTA-PAMAM-[nimotuzumab-F(ab’)2] conjugate with 177Lu resulted in (177Lu-DOTA)n-PAMAM-[nimotuzumab-F(ab’)2] with radiochemical purity > 99% after purification with a PD-10 column. Further studies still need to be performed in order to confirm the potential of this radioimmunoconjugate as a radioimmunotherapeutic agent for EGFR overexpressed cancers.

Authors and Affiliations

Titis Sekar Humani, Sutari Sutari, Triningsih Triningsih, Martalena Ramli, Rien Ritawidya, Ratna Dini Haryuni

Keywords

Related Articles

Assessing Resistance and Bioremediation Ability of Enterobacter sp. Strain Saw-1 on Molybdenum in Various Heavy Metals and Pesticides

One of the most economical approaches for removal of toxic compounds is bioremediation. In the long term, bioremediation is economic and feasible compared to other methods, such as physical or chemical methods. A bacteri...

Multi-wavelength Fibril Dynamics and Oscillations above Sunspot-II Wave Propagation Signature

In this work, the dynamics of one particular fibril were investigated through high-resolution multi-wavelength images with high cadence obtained from the Dutch Open Telescope. Based on exceptional observation data of Act...

Study on Transport Properties of Chitosan Membrane in Different Types of Electrolytes

In this study, the electrical properties of chitosan membrane in different types of electrolytes were investigated by analyzing the current-voltage (I‑V) curve. The membrane used was chitosan membrane 2%. The different e...

Thickness Effect on Fluctuation of Electron States in Thin Film and Implications for Lattice Constant Change Due to Size Reduction

We propose a model for predicting the fluctuation of electron states in thin films as a function of film thickness. The model is derived based on the assumption of the existence of potential barrier fluctuation on the fi...

New Generalized Algorithm for Developing k-Step Higher Derivative Block Methods for Solving Higher Order Ordinary Differential Equations

This article presents a new generalized algorithm for developing k-step (m+1)th derivative block methods for solving mth order ordinary differential equations. This new algorithm utilizes the concept from the conventiona...

Download PDF file
  • EP ID EP314949
  • DOI 10.5614/j.math.fund.sci.2017.49.3.4
  • Views 128
  • Downloads 0

How To Cite

Titis Sekar Humani, Sutari Sutari, Triningsih Triningsih, Martalena Ramli, Rien Ritawidya, Ratna Dini Haryuni (2017). Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancer Treatment. Journal of Mathematical and Fundamental Sciences, 49(3), 258-268. https://europub.co.uk./articles/-A-314949